CC BY 4.0 · World J Nucl Med 2023; 22(01): 043-047
DOI: 10.1055/s-0042-1757282
Case Report

Use of 99mTc-DTPA Scintigraphy in Evaluation of Ureteral Laceration Due to Transurethral Lithotripsy in a Patient with Nephrolithiasis

Esmaeil Gharepapagh
1   Medical Radiation Sciences Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
,
Ashraf Fakhari
1   Medical Radiation Sciences Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
,
Afshar Zomorrodi
2   Department of Urology, Tabriz University of Medical Sciences, Tabriz, Iran
,
Shahram Dabiri Oskuei
1   Medical Radiation Sciences Research Team, Tabriz University of Medical Sciences, Tabriz, Iran
› Author Affiliations

Abstract

Transurethral lithotripsy (TUL) procedure via ureteroscopy as an invasive method for nephrolithiasis treatment would lead to urinary tract injuries. In this reported case, the procedure caused severe damage to the left ureter that was detected by 99mTc-diethylenetriaminepentaacetic acid (99mTc-DTPA) scan. Generally, the TUL procedure through the ureter scope is used to manage urinary tract stones. In this case, the TUL was performed on a patient with a history of nephrolithiasis. Following that, she was accompanied with abdominal pain and discomfort, so 99mTc-DTPA scintigraphy was performed to evaluate the urinary tract system. The scintigraphy showed a severe damage to the left ureter that finally resulted in autotransplantation. The control 99mTc-DTPA scintigraphy performed 3 weeks after revealed no visible urinary leakage. In this case, the 99mTc-DTPA scan prevented the patient from dangerous complications. So, 99mTc-DTPA scan could be performed after TUL and ureteroscopy to detect probable risks.

Authors' Contributions

Fakhari organized the investigation and was a major contributor to writing the manuscript. Gharepapagh interpreted scintigraphy regarding the 99mTc-DTPA renal scan. Afshar Zomorrodi performed auto-transplantation surgery. Shahram Dabiri Oskuei reviewed the manuscript.




Publication History

Article published online:
28 October 2022

© 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Sorokin I, Pearle MS. Medical therapy for nephrolithiasis: State of the art. Asian J Urol 2018; 5 (04) 243-255
  • 2 Basillote JB, Lee DI, Eichel L, Clayman RV. Ureteroscopes: flexible, rigid, and semirigid. Urol Clin North Am 2004; 31 (01) 21-32
  • 3 Taie K, Jasemi M, Khazaeli D, Fatholahi A. Prevalence and management of complications of ureteroscopy: a seven-year experience with introduction of a new maneuver to prevent ureteral avulsion. Urol J 2012; 9 (01) 356-360
  • 4 Taylor AT. Radionuclides in nephrourology, part 1: radiopharmaceuticals, quality control, and quantitative indices. J Nucl Med 2014; 55 (04) 608-615
  • 5 Khan SR, Pearle MS, Robertson WG. et al. Kidney stones. Nat Rev Dis Primers 2016; 2: 16008
  • 6 Rabani SM, Moosavizadeh A. Management of large proximal ureteral stones: a comparative clinical trial between transureteral lithotripsy (TUL) and shock wave lithotripsy (SWL). Nephrourol Mon 2012; 4 (03) 556-559
  • 7 Durand E, Chaumet-Riffaud P, Grenier N. Functional renal imaging: new trends in radiology and nuclear medicine. Semin Nucl Med 2011; 41 (01) 61-72
  • 8 Damasio MB, Bodria M, Dolores M. et al. Comparative study between functional MR urography and renal scintigraphy to evaluate drainage curves and split renal function in children with congenital anomalies of kidney and urinary tract (CAKUT). Front Pediatr 2020; 7: 527
  • 9 Mettler F, Guiberteau M. Essentials of Nuclear Medicine and Molecular Imaging. 7th ed.. Philadelphia: Elsevier; 2019: 287
  • 10 Chervu LR, Blaufox MD. Renal radiopharmaceuticals–an update. Semin Nucl Med 1982; 12 (03) 224-245